Drug Profile
Amsacrine
Alternative Names: Amekrin; Amsa P-D; Amsidine; Amsidyl; CI 880; m AMSA; NSC 141549; NSC 156303; NSC 249992; SN 11841Latest Information Update: 25 Sep 2021
Price :
$50
*
At a glance
- Originator Auckland Cancer Society Research Centre
- Class Aminoacridines; Antineoplastics; Small molecules
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Leukaemia
Most Recent Events
- 18 Apr 2016 ProStrakan is now called Kyowa Kirin International
- 21 Apr 2011 ProStrakan has been acquired by Kyowa Hakko Kirin
- 31 Jan 2004 OTL Pharma has been acquired by, and merged into, Strakan